During the past decade, Ch Laval conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ch Laval" #1 sponsor was "Nantes University Hospital" with 4 trials, followed by "Rennes University Hospital" with 3 trials sponsored, "University Hospital, Angers" with 3 trials sponsored, "Biotronik France" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ch Laval" #1 collaborator was "Ministry of Health, France" with 2 trials as a collaborator, "Biotronik SE & Co. KG" with 1 trials as a collaborator and "Intergroupe Francophone du Myelome" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ch Laval" are "Addictions" (1 trials), "Anemia" (1 trials), "Atrial Fibrillation" (1 trials), "Atrial Flutter" (1 trials) and "Atrial Tachycardia" (1 trials). Many other conditions were trialed in "Ch Laval" in a lesser frequency.

Most popular intervention types in "Ch Laval" are "Other" (5 trials), "Device" (1 trials), "Drug" (1 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adapted physical activity" (1 trials), "Blood Collection" (1 trials), "Genetic study of DNA copies" (1 trials), "Hydroxychloroquine" (1 trials) and "Insignia Ultra and Insignia AVT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ch Laval" are 12 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ch Laval". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Ch Laval, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ch Laval, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".